Table 3.
R = | |||||||
Cell Line | PR-104A | EF5 | EF3 | Pimo | F-miso | RSU1069 | HX4 |
NfsA_Ec | 985 | 1600 | 1050 | 71 | 690 | 108 | 52 |
NfsB_Ec | 1643 | 57 | 60 | 2 | 203 | 13 | 103 |
YcaK_Ec | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
YieF_Ec | 2 | 1 | 2 | 1 | 1 | 2 | 1 |
AzoR_Ec | 3 | 1 | 1 | 1 | 1 | 2 | 3 |
MdaB_Ec | 33 | 1 | 1 | 1 | 1 | 2 | 1 |
WrbA_Ec | 4 | 2 | 1 | 1 | 1 | 2 | 1 |
KefF_Ec | 3 | 1 | 1 | 1 | 1 | 1 | 1 |
YcdI_Ec | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
YdjA_Ec | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
NemA_Ec | 14 | 4 | 8 | 2 | 28 | 5 | 4 |
Cell lines were exposed to compounds for 18 hours at a range of concentrations followed by 5 days growth in drug-free media. IC50 values were determined as the concentration required to inhibit cell growth by 50% of untreated controls. Values in the table represent the fold change in IC50 of the stated cell line relative to HCT116 WT cells. Raw IC50 values are provided in Supplementary table 1.